| 前收市價 | 7.50 |
| 開市 | 7.50 |
| 買盤 | 4.80 |
| 賣出價 | 9.40 |
| 拍板 | 17.50 |
| 到期日 | 2024-08-16 |
| 今日波幅 | 7.50 - 7.50 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 1 |
ZacksRepligen (RGEN) Soars 4.4%: Is Further Upside Left in the Stock?
Repligen (RGEN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ZacksAnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates
AnaptysBio (ANAB) delivered earnings and revenue surprises of -6.49% and 57.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksAnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
